Lyra Therapeutics, INC. (LYRA) SEC Filings — 2024
23 SEC filings for Lyra Therapeutics, INC. (LYRA) in 2024.
Filings
- Perceptive Advisors Adjusts Lyra Therapeutics Stake — SC 13D/A · Dec 16, 2024
- Lyra Therapeutics Appoints New Directors, Adjusts Executive Pay — 8-K · Dec 13, 2024
- Lyra Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lyra Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lyra Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Perceptive Advisors Adjusts Lyra Therapeutics Stake — SC 13D/A · Aug 15, 2024
- Lyra Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- Lyra Therapeutics Faces Nasdaq Delisting Notice — 8-K · Jul 23, 2024
- Lyra Therapeutics Files 8-K with Corporate Updates — 8-K · Jun 18, 2024
- Lyra Therapeutics Files 8-K Amendment on Disposal Costs — 8-K/A · Jun 7, 2024
- Lyra Therapeutics Directors Depart, Costs Disclosed — 8-K · May 21, 2024
- Lyra Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 30, 2024
- Lyra Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- Lyra Therapeutics Appoints New CMO, Director — 8-K · Apr 19, 2024
- Lyra Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 22, 2024
- Lyra Therapeutics Files 8-K on Financials — 8-K · Mar 21, 2024
- Lyra Therapeutics Appoints New Chief Medical Officer — 8-K · Mar 1, 2024
- Perceptive Advisors Amends Lyra Therapeutics Stake — SC 13D/A · Feb 14, 2024
- Lyra Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Lyra Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Lyra Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Lyra Therapeutics, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Lyra Therapeutics Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 8, 2024